JON M WARDNER

Allopathic & Osteopathic Physicians|Physical Medicine & Rehabilitation YPSILANTI, MI NPI 1962493908

General Payments — all program years on this page

$2,568.06

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 141
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $455.98 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $455.9820

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $669.9044
2019 $660.1738
2020 $74.435
2021 $19.191
2022 $107.995
2023 $580.4028
2024 $455.9820

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1091960894 Ipsen Biopharmaceuticals, Inc $24.23 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1091960896 Ipsen Biopharmaceuticals, Inc $23.33 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1091960898 Ipsen Biopharmaceuticals, Inc $19.77 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106308874 ABBVIE INC. $17.77 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106308876 ABBVIE INC. $17.33 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106308878 ABBVIE INC. $24.47 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106308880 ABBVIE INC. $17.61 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106308882 ABBVIE INC. $19.54 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106308884 ABBVIE INC. $12.21 06/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106308886 ABBVIE INC. $25.54 06/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106308888 ABBVIE INC. $24.90 07/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106308890 ABBVIE INC. $14.35 08/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106308892 ABBVIE INC. $18.52 10/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106308894 ABBVIE INC. $7.31 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119002365 Otsuka America Pharmaceutical, Inc. $16.27 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1128533780 TRICE MEDICAL, INC. $37.31 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137950630 Merz Pharmaceuticals, LLC $40.03 01/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137950632 Merz Pharmaceuticals, LLC $34.54 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137950634 Merz Pharmaceuticals, LLC $39.02 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144715913 TerSera Therapeutics LLC $21.93 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.